NO934477L - PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof - Google Patents

PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof

Info

Publication number
NO934477L
NO934477L NO934477A NO934477A NO934477L NO 934477 L NO934477 L NO 934477L NO 934477 A NO934477 A NO 934477A NO 934477 A NO934477 A NO 934477A NO 934477 L NO934477 L NO 934477L
Authority
NO
Norway
Prior art keywords
peg
water
polymeric reagents
soluble polymeric
hydrazone
Prior art date
Application number
NO934477A
Other languages
Norwegian (no)
Other versions
NO934477D0 (en
Inventor
David E Wright
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO934477D0 publication Critical patent/NO934477D0/en
Publication of NO934477L publication Critical patent/NO934477L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/16—Cyclic ethers having four or more ring atoms
    • C08G65/20—Tetrahydrofuran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

Det blir beskrevet fremgangsmåter og forbindelser for modifisering av polypeptider med PEG eller andre vannoppløsellge organiske polymerer. Nye vannoppløselige polymerreagenser blir fremskaffet. De vannoppløsellge polymerreagensene omfatter hydrazln, hydrazinkarboksylat, semlkarbazld, tiosemikarbazid, karbonsyredlhydrazld, karbazid, tiokarbazid og arylhydrazidderivater så vel som oksylaminderivater av vannoppløsellge organiske polymerer, slik som poly- etylenglykol, polypropylenglykol, polyoksyetylert polyol, heparln, heparlnfragmenter, dekstran, poly- sakkarider, polyaminosyrer og polyvlnylalkohol. Det ble også fremskaffet aktuelle peptider som er derlvatisert ved foreliggende vannoppløselige polymer- reagenser . Det ble også beskrevet sett for modifisering av polypeptider med foreliggende vannoppløselige polymer- reagenser .Methods and compounds for modifying polypeptides with PEG or other water-soluble organic polymers are described. New water-soluble polymeric reagents are provided. The water-soluble polymeric reagents include hydrazine, hydrazine carboxylate, semicarbazide, thiosemicarbazide, carboxylic acid dihydrazide, carbazide, thiocarbazide and arylhydrazide derivatives as well as oxyamine paraffinic acid, polyethylene glycol, polyethylene glycol, and polyvinyl alcohol. Relevant peptides were also obtained which are derivatized by the present water-soluble polymeric reagents. Kits were also described for modifying polypeptides with the present water-soluble polymeric reagents.

NO934477A 1992-12-09 1993-12-08 PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof NO934477L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98773992A 1992-12-09 1992-12-09
US4505293A 1993-04-07 1993-04-07

Publications (2)

Publication Number Publication Date
NO934477D0 NO934477D0 (en) 1993-12-08
NO934477L true NO934477L (en) 1994-06-10

Family

ID=26722325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934477A NO934477L (en) 1992-12-09 1993-12-08 PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof

Country Status (5)

Country Link
JP (1) JPH07196925A (en)
KR (1) KR100254650B1 (en)
AU (1) AU5238393A (en)
FI (1) FI935485A (en)
NO (1) NO934477L (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586398B1 (en) * 2000-04-07 2003-07-01 Amgen, Inc. Chemically modified novel erythropoietin stimulating protein compositions and methods
ES2320101T3 (en) * 2000-10-16 2009-05-19 Chugai Seiyaku Kabushiki Kaisha CONJUGATED ERYTHROPOYETINE WITH MONO-PEG.
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
JPWO2003064462A1 (en) * 2002-02-01 2005-05-26 中外製薬株式会社 PEG-conjugated PTH or PEG-conjugated PTH derivative
DE10209822A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of low molecular weight substances to a modified polysaccharide
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
DE02020425T1 (en) * 2002-09-11 2004-07-15 Fresenius Kabi Deutschland Gmbh Hasylated polypeptides, especially hasylated erythropoietin
KR101045422B1 (en) 2002-09-11 2011-06-30 프레제니우스 카비 도이치란트 게엠베하 Method of producing hydroxyalkyl starch derivatives
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
DE202005021885U1 (en) 2004-03-11 2011-03-03 Fresenius Kabi Deutschland Gmbh Hydroxyalkyl starch-protein conjugates prepared by reductive amination
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
PL2586456T3 (en) 2004-10-29 2016-07-29 Ratiopharm Gmbh Remodeling and glycopegylation of fibroblast growth factor (FGF)
EP2284191A3 (en) * 2004-12-22 2011-07-20 Ambrx, Inc. Process for the preparation of hGH
EP2514757A3 (en) 2005-01-10 2014-03-05 ratiopharm GmbH Glycopegylated granulocyte colony stimulating factor
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
JP5570809B2 (en) * 2006-09-01 2014-08-13 ノボ ノルディスク ヘルス ケア アーゲー Modified protein
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
KR20150064246A (en) 2007-04-03 2015-06-10 바이오제너릭스 게엠베하 Methods of treatment using glycopegylated g―csf
EP2170919B8 (en) 2007-06-12 2016-01-20 ratiopharm GmbH Improved process for the production of nucleotide sugars
JP2012512812A (en) 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト PDGF fusion protein incorporated into fibrin foam
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules
JPWO2009113578A1 (en) 2008-03-13 2011-07-21 味の素株式会社 Carbonyl compound removal material
JP5418360B2 (en) 2009-03-27 2014-02-19 日油株式会社 Method for producing polyoxyalkylene derivative
SG178051A1 (en) * 2009-07-27 2012-03-29 Lipoxen Technologies Ltd Glycopolysialylation of non-blood coagulation proteins
CN104530182A (en) * 2009-07-27 2015-04-22 利普森技术有限公司 Glycopolysialylation of non-blood coagulation proteins
AU2010281453C1 (en) * 2009-07-27 2019-08-15 Takeda Pharmaceutical Company Limited Blood coagulation protein conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06506217A (en) * 1991-03-18 1994-07-14 エンゾン，インコーポレーテッド Hydrazine-containing conjugates of polypeptides or glycopolypeptides and polymers

Also Published As

Publication number Publication date
KR940014430A (en) 1994-07-18
FI935485A0 (en) 1993-12-08
FI935485A (en) 1994-06-10
KR100254650B1 (en) 2000-05-01
NO934477D0 (en) 1993-12-08
AU5238393A (en) 1994-06-23
JPH07196925A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
NO934477L (en) PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof
AU678814B2 (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
ATE193303T1 (en) OLIGOPEPTIDES WITH FUNGICIDAL ACTIVITY
ES2142363T3 (en) MATERIALS AND METHODS FOR THE HYPERSECRETION OF AMINO ACIDS.
IE45086L (en) Amino acids.
CA2061487A1 (en) Coating material stabilised against light-induced degradation
EE02970B1 (en) Process for conditioning water - soluble substances
NO20020759D0 (en) N <o> 6 </o> heterocyclic substituted adenosine derivatives
EP0196112A3 (en) Aqueous high solids coating compositions
EP0721943A4 (en) Azole derivative and pharmaceutical composition thereof
FI935465A (en) Thermoplastic composition, process for preparation thereof and use thereof
ATE128998T1 (en) CURABLE COMPOSITION CONTAINING A CRYSTALLIZABLE POLYMER.
FI810029L (en) FRAMSTAELLNING AV HYDROXIDFOERENINGAR GENOM ELEKTROKEMISK REDUKTION
NO176880C (en) Analogous Process for Preparing Therapeutically Active Pyrimidinylpiperazinylalkylazole Derivatives
DE59300631D1 (en) Biodegradable, aqueous dispersions.
GB1274501A (en) Cationic monoazo dyestuffs
ES2121554A1 (en) Process for obtaining 14-hydroxymorphines by the photo- oxidation of morphine alkaloids with an alkoxydiene system in the C ring
DE69317122D1 (en) METHOD FOR PRODUCING TRIAZOLONE DERIVATIVES
CA2301305A1 (en) A polyethylene crosslinkable composition
ATA4682003A (en) Runge
SE9901859D0 (en) An animal stall with gates
GB1338834A (en) Substituted furancarboxylic acid cycloalkylamide
SE8005599L (en) SET TO MAKE AN ANTIBIOTIC
DK0595164T3 (en) 4-Heterocyclophenyl-substituted dihydropyridines
ATE166654T1 (en) USE OF HALOGENATED BETA-LACTAMS FOR PRODUCING 3-HYDROXYCEPHEM DERIVATIVES